Opus Genetics IRD Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's operating income?
- Opus Genetics (IRD) reported operating income of -$14.36M in Q1 2026.
- How has Opus Genetics's operating income changed year-over-year?
- Opus Genetics's operating income decreased by 44.7% year-over-year, from -$9.93M to -$14.36M.
- What is the long-term trend for Opus Genetics's operating income?
- Over 4 years (2021 to 2025), Opus Genetics's operating income has grown at a 14.2% compound annual growth rate (CAGR), from -$22.71M to -$38.6M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.